← back to search

Tim Waterboer

German Cancer Research Center · DE
Area of research
Epidemiology · Otorhinolaryngology · cancer
Research interest
Research interests include Cervical Cancer and HPV Research, Head and Neck Cancer Studies, Polyomavirus and related diseases, and Helicobacter pylori-related gastroenterology studies.
h-index
65
citations
16,744
works
689
NIH funding
primary concept
email

Recent publications

Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers
Clinical Cancer Research 2025cited by 22position: middledoi
Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study
EClinicalMedicine 2025cited by 13position: middledoi
Viral and immune dynamics of genital human papillomavirus infections in young women with high temporal resolution
PLoS Biology 2025cited by 13position: middledoi
Genome-wide association study identifies common variants associated with breast cancer in South African Black women
Nature Communications 2025cited by 12position: middledoi
Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus–associated oropharynx cancer early detection
JNCI Journal of the National Cancer Institute 2025cited by 7position: middledoi
Basal T cell activation predicts yellow fever vaccine response independently of cytomegalovirus infection and sex-related immune variations
Cell Reports Medicine 2025cited by 6position: middledoi
First trimester maternal infections and offspring congenital heart defects: a meta-analysis
European Heart Journal 2025cited by 6position: middledoi
Efficacy of oral rinse and other detection methods in detecting oral human papillomavirus infections: The Oromouth cohort study
Journal of Infection 2025cited by 5position: middledoi
Post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNA
Oral Oncology 2025cited by 5position: middledoi
Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma
JAMA Otolaryngology–Head & Neck Surgery 2025cited by 4position: middledoi
Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites
Nature Communications 2025cited by 3position: middledoi
Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study
BMC Infectious Diseases 2025cited by 3position: middledoi
Epstein-Barr virus (EBV) serology and its impact on oral human papillomavirus (HPV) infection outcomes in children during early childhood
Microbiology Spectrum 2025cited by 2position: middledoi
A population-based case–control study of COVID-19: methodological considerations on the role of testing bias
Journal of Public Health 2025cited by 1position: middledoi
AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells
Frontiers in Immunology 2025cited by 1position: middledoi
SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures
PLoS ONE 2025cited by 1position: middledoi
Epstein-Barr Virus Antibody Response Patterns in Endemic and Nonendemic Cases of Nasopharyngeal Carcinoma
The Journal of Infectious Diseases 2025cited by 1position: middledoi
Performance of Dried Blood Spot Cards for Serologic Detection of HPV16 Antibodies in Oropharyngeal Squamous Cell Carcinoma Patients
Microorganisms 2025cited by 1position: middledoi
Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma development
Med 2025cited by 1position: middledoi
Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settings
EBioMedicine 2025cited by 1position: lastdoi
Human herpesvirus 7 and the risk of developing multiple sclerosis
Brain Communications 2025cited by 1position: middledoi
Risk factors associated with IgG seropersistence to <i>Chlamydia trachomatis</i> and <i>Mycoplasma genitalium</i>
Epidemiology and Infection 2025cited by 1position: middledoi
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma
PubMed 2025cited by 1position: middledoi
Associations of common infections with frailty and mortality in two UK cohort studies
medRxiv 2025cited by 1position: middledoi
FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice
Cell 2024cited by 53position: middledoi
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study
Nature Communications 2024cited by 42position: middledoi
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis
Brain 2024cited by 23position: middledoi
Human papillomavirus‐driven head and neck cancers in Japan during 2008–2009 and 2018–2019: The BROADEN study
Cancer Science 2024cited by 15position: lastdoi
Helper T cell immunity in humans with inherited CD4 deficiency
The Journal of Experimental Medicine 2024cited by 14position: middledoi
Multi-feature next-generation liquid biopsy for diagnosis and prognosis in HPV-associated head and neck cancer.
Journal of Clinical Oncology 2024cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Pawlita · Heidelberg University146 papers (2012–2022)Julia Butt · German Cancer Research Center74 papers (2016–2025)Nicole Brenner · German Cancer Research Center60 papers (2018–2025)Angelika Michel · Heidelberg University46 papers (2012–2020)Noemi Bender · Heidelberg University35 papers (2018–2023)Anna R. Giuliano · Moffitt Cancer Center23 papers (2012–2025)Andy Ness · Palo Alto University20 papers (2018–2023)Tomas Olsson · Karolinska University Hospital17 papers (2016–2024)Miranda Pring · University of Bristol17 papers (2018–2025)Freddy Sitas · South African Medical Research Council17 papers (2012–2025)Allan Hildesheim · Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud16 papers (2014–2025)Ingrid Kockum · Karolinska Institutet15 papers (2016–2024)Lea Schroeder · German Cancer Research Center14 papers (2017–2025)Dana E. Rollison · Moffitt Cancer Center14 papers (2012–2022)Meira Epplein · Duke University14 papers (2017–2022)Gypsyamber DʼSouza · Instituto Lauro de Souza Lima13 papers (2016–2024)Massimo Tommasino · Istituti di Ricovero e Cura a Carattere Scientifico13 papers (2012–2023)Carole Fakhry · Johns Hopkins University13 papers (2017–2024) · 12 papers (2015–2025) · 12 papers (2020–2025)